Steve Jobs has been reassuring associates and colleagues about the state of his health, according to the New York Times. After undergoing treatment four years ago for a rare form of pancreatic cancer, Jobs is “cancer-free,” according to sources close to him, but he did undergo a surgical procedure this year to address a problem that was contributing to a loss of weight.
A great deal of speculation over Job’s health and uncertainty regarding his future prospects as CEO of Apple contributed to a sharp decline in Apple’s stock yesterday, after the company reported solid earnings and a muted outlook for the next quarter on Monday after the markets closed. Today AAPL is trading at $164 per share, $2 higher than yesterday’s close, but up $18 from yesterday’s intra-session lows.
Much of the speculation surrounding Jobs’ health began in response to his appearance at the WWDC conference last month, where he appeared wan and quite thin. According to an industry executive who spoke with Jobs and was a source for the Times report, Jobs had run a high fever for the week preceding WWDC. Apple had previously said that Jobs had come down with a “common bug” which was treated with antibiotics, and additional speculation and concern were sparked by remarks in the Monday conference call, in which the company said Jobs’ health is “a private matter.”